<SEC-DOCUMENT>0000920465-17-000062-index.html : 20170829 <SEC-HEADER>0000920465-17-000062.hdr.sgml : 20170829 <ACCEPTANCE-DATETIME>20170829163347 ACCESSION NUMBER: 0000920465-17-000062 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20170828 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20170829 DATE AS OF CHANGE: 20170829 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36282 FILM NUMBER: 171058323 BUSINESS ADDRESS: STREET 1: 10182 TELESIS COURT, 6TH FLOOR CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 10182 TELESIS COURT, 6TH FLOOR CITY: SAN DIEGO STATE: CA ZIP: 92121 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>a8-kaugust2017.htm <DESCRIPTION>8-K <TEXT> Document 1 - file: a8-kaugust2017.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>ljpc-501ndafinal.htm <DESCRIPTION>EXHIBIT 99.1 <TEXT> Document 2 - file: ljpc-501ndafinal.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>ljpc501ndafinalimage1.jpg <TEXT> Document 3 - file: ljpc501ndafinalimage1.jpg
</DOCUMENT> </SEC-DOCUMENT>